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Human cytomegalovirus is a herpesvirus that induces numerous cellular processes upon infection. Among these are
activation of cyclin-dependent kinase 2, which regulates cell cycle progression in G1 and S phase. We report here that
inhibition of cellular Cdk2 activity blocks HCMV replication. Inhibition of Cdk2 activity by roscovitine inhibits HCMV DNA
synthesis, production of infectious progeny, and late antigen expression in infected cells in a dose-dependent manner.
HCMV replication is also inhibited by the expression of a Cdk2 dominant negative mutant, whereas expression of wild-type
Cdk2 has no effect on viral replication. These data indicate that activation of cellular Cdk2 is necessary for HCMV replication.
q 1997 Academic Press
INTRODUCTION infected cells arrest in late G1 (Bresnahan et al., 1996;
Lu and Shenk, 1996; Dittmer and Mocarski, 1997). These
Human cytomegalovirus (HCMV)2 is a ubiquitous
latter findings are consistent with the observation that
pathogenic herpesvirus that infects over 80% of the popu-
HCMV infection does not alter the abundance or activity
lation and causes a variety of disease conditions after
of cyclin A/Cdk2 (Bresnahan et al., 1996), whose activity
prenatal infection or in patients with suppressed immune
is necessary for entry into and progression through S
functions (organ transplantation, HIV infection) (Rubin,
phase (Resnitzky et al., 1995; Girard et al., 1991).
1990; Schooley, 1990; Alford et al., 1990). Increases in
We have proposed that the late G1-arrested state in-
the frequency of organ transplantation and the incidence
duced by productive HCMV infection provides a cellular
of AIDS have focused attention upon the HCMV life cycle,
environment that is advantageous for HCMV replication
with a view toward discovering potential means of atten-
in that metabolic precursors (i.e., nucleotides) are abun-
uating primary and/or reactivated infection. It has been
dantly available for viral replication, while cellular DNA
determined that productive HCMV infection of postmitotic synthesis is inhibited, thus allowing uncompeted viral
cells stimulates cell cycle progression (Bresnahan et al.,
access to these precursors. A prominent aspect of this
1996; Jault et al., 1995; Lu and Shenk, 1996; Poma et
G1-arrested state is a substantial increase in the abun-
al., 1996; Dittmer and Mocarski, 1997). Although there
dance and activity of cyclin E/Cdk2 (Bresnahan et al.,
appears to be a general agreement that productive
1996; Jault et al., 1995). The increase in cyclin E kinase
HCMV infection induces cellular processes that resem-
activity results from an increase in the abundance of
ble progression through G1 phase upon infection of ar-
cyclin E (Bresnahan et al., 1996; Jault et al., 1995), the
rested cells, it is still controversial whether or not these
translocation of Cdk2 from the cytoplasm to the nucleus,3
cells are capable of entering S phase. Several reports
and inhibition of the Cdk2 inhibitors p21Cip1 and p27Kip1
have suggested that productively infected cells proceed
(Bresnahan et al., 1996). These findings suggest that
through S phase and subsequently arrest (Jault et al.,
HCMV replication may be related to the virus’ ability to
1996; Poma et al., 1996), while a number of more recent
activate cyclin E/Cdk2 kinase activity. If this hypothesis is
(Bresnahan et al., 1996; Lu and Shenk, 1996; Dittmer and correct, inhibition of Cdk2 activation should inhibit HCMV
Mocarski, 1997) and earlier reports (Albrecht et al., 1989;
replication.
DeMarchi, 1983) have demonstrated that productive
HCMV infection inhibits cellular DNA synthesis, so that
MATERIALS AND METHODS
Cell culture and transfections1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (409) 772-5065. E-mail: thomas.albrecht@utmb.edu.
Human diploid embryonic lung fibroblasts (LU), pas-2 Abbreviations used: HCMV, human cytomegalovirus; Cdk2, cyclin-
sage 12 –20, or U-373 astrocytoma cells from the Ameri-dependent kinase 2; PAA, phosphonoacetic acid; EMEM, Eagle’s mini-
mum essential medium; FBS, fetal bovine serum; SDS – PAGE, sodium
dodecyl sulfate – polyacrylamide gel electrophoresis; PFU, plaque form-
ing units; wt, wild-type; HA, hemagglutinin. 3 Bresnahan et al., submitted for publication.
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can Type Culture Collection (ATCC HTB-17) were cul- to a final reaction volume of 10 ml. Kinase reactions were
carried out at 377 for 30 min and subsequently stoppedtured in Eagle’s minimum essential medium with Earle’s
salts (EMEM) with 10% fetal bovine serum (FBS) and by addition of 21 sample buffer.
penicillin (100 units/ml)/streptomycin(100 mg/ml) at 377
Slot blot hybridization and virus yield reductionin a 5% CO2 atmosphere. LU cells were density arrested
assaysand infected as previously described (Bresnahan et al.,
1996). For treatment of infected cells with roscovitine or Total DNA from infected cells was isolated by phenol
olomoucine LU cells were density-arrested and infected extraction. Equal aliquots of DNA (2 mg) were heated to
as described previously (Bresnahan et al., 1996). Follow- 957 and transferred to Hybond/ (Amersham) membranes
ing incubation with HCMV stock the virus inoculum was in 101 SSC (11 SSC: 0.15 M NaCl, 0.015 M sodium
removed and replaced with medium containing various citrate) buffer, using a slot blot apparatus. Membranes
concentrations of either roscovitine or olomoucine. Ros- were denatured for 5 min in 0.5 M NaOH– 1.5 M NaCl,
covitine or olomoucine stocks were prepared in dimethyl- neutralized in 1.5 M NaCl, 0.5 M Tris – HCl, pH. 7.2, 0.001
sulfoxide (DMSO) at a concentration of 10 mM. Infected M EDTA for 5 min, and then dried for 10 min in a vacuum
cultures not treated with drug always contained a volume oven at 807. Filters were prehybridized in Rapid-Hyb
of DMSO (vehicle) equal to that contained in the highest buffer (Amersham) for 3 hr at 607. Hybridization was car-
concentration of roscovitine used. For transfection exper- ried out by overnight incubation in the same buffer at
iments, U-373 cultures were subcultured 24 hr prior to 607. A 253-bp PCR amplified immediate early fragment
transfection into 100-mm dishes. Cells were transfected from HCMV strain AD169 was 32P-labeled by random
with 10 mg of pCMVCdk2-wt-HA or pCMVCdk2-dn-HA priming and used as probe. Filters were washed twice
with Tfx-50 lipofection reagent (Promega) for 2 hr with a in 0.1% SDS in 21 SSC at room temperature for 15 min
3:1 lipofectin:DNA ratio. Cells were harvested 48 hr after and then 0.1% SDS in 0.21 SSC at 607 for 20 min and
transfection and assayed for HA expression and kinase exposed to film (Kodak XAR-5) at 0807. Virus yields were
activity. For immunofluorescent staining, transfected assayed as previously described (Albrecht and Weller,
cells were dissociated with trypsin, seeded into 35-mm 1980).
dishes containing sterile glass coverslips, and cultured
for 24 hr before being infected as described previously Flow cytometry
(Bresnahan et al., 1996).
LU cells were assayed for DNA content as described
previously (Bresnahan et al., 1996). Briefly, cells wereImmunofluorescent staining, kinase assays, and
harvested by trypsinization, washed in PBS, collected byWestern blotting
sedimentation, suspended in low salt buffer [3% polyeth-
ylene glycol, propidium iodine (5 mg/ml), 0.1% Triton X-Coverslips were processed for immunofluorescent
100, 4 mM sodium citrate, RNase A (100 mg/ml, addedstaining as previously described (Bresnahan et al., 1996).
just before use)], and incubated for 20 min at 377. HighFor Western blotting and kinase assays, cells were har-
salt buffer [3% polyethylene glycol, propidium iodine (5vested by trypsinization, collected by sedimentation, and
mg/ml), 0.1% Triton X-100, 400 mM NaCl] was then added,lysed in NP-40 lysis buffer (50 mM Tris, pH 7.4, 150 mM
and the cells were maintained at 47 overnight. The cellu-NaCl, and 0.5% NP-40, with 1 mM NaVO3 , 50 mM NaF,
lar DNA content was analyzed using a Becton – Dickinson1 mM PMSF, 1 mM DTT, 25 mg/ml leupeptin, 25 mg/ml
FACScan flow cytometer. For bromodeoxyuridine incor-trypsin inhibitor, 25 mg/ml aprotinin, 1 mM benzamide,
poration LU cells treated with 15 mM roscovitine for 96and 25 mg/ml pepstatin A added just before use). Cellular
hr were washed twice with PBS and then cultured indebris was removed by sedimentation and the reserved
fresh EMEM containing 10% FBS and 0.1 mM bromo-supernatant fluids were assayed for protein concentra-
deoxyuridine for 24 hr. The cells were fixed in ace-tion (Bradford, 1976), and then used for kinase assays
tone:methanol (1:1) at 0207 for 10 min and stained foror immunoblotting as described previously (Bresnahan
bromodeoxyuridine incorporation as described by Car-et al., 1996; Dulic et al., 1992). Cyclin-dependent kinase
doso et al. (1993).activity in vitro, in the presence of roscovitine, was deter-
mined as described previously (Bresnahan et al., 1996;
RESULTSDulic et al., 1992) with slight modifications. Briefly, follow-
ing immunoprecipitation, kinase reactions were carried Activation of cyclin E/Cdk2 by HCMV
out in a total reaction volume of 10 ml. Each reaction
contained 5 ml of 21 kinase buffer (40 mM Tris – HCl, pH The data shown in Fig. 1 illustrate HCMV’s ability to
activate Cdk2. LU cells were arrested by contact inhibi-7.5, 8 mM MgCl2), containing 2.4 mg of histone H1 as
substrate. Roscovitine was added to the reaction along tion and then infected with HCMV. Cell lysates were
prepared before infection (0 hr) and 48 hr postinfectionwith 1 ml [g-32P]ATP (10 Ci/mmol) to obtain a final concen-
tration of 20 mM ATP. Double-distilled H2O was added and immunoprecipitated with anti-Cdk2 antibody, and the
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could inhibit accumulation of HCMV DNA in a dose-de-
pendent manner after addition to infected LU cells.
Density-arrested LU cells were infected for 1 hr after
which the virus inoculum was removed and replaced with
medium containing various concentrations of roscovitine.
Total DNA was isolated from LU cells that had been
infected for 72 hr, and the abundance of HCMV DNA was
determined by slot blot hybridization. As Fig. 2B shows,
HCMV DNA abundance was reduced by 50% in the
presence of 1 mM roscovitine; and viral DNA abundance
was reduced by90% by 10 mM inhibitor. Consequently,
roscovitine significantly reduced the production of infec-
tious HCMV progeny, as shown in Fig. 2C. Infectious
HCMV yields were reduced by 90% after addition of
FIG. 1. Cdk2 activation in HCMV-infected cells. LU cells were growth
arrested by contact inhibition and infected with HCMV as described
previously (Bresnahan et al., 1996). Prior to infection (0 hr) or 48 hr
postinfection cells were harvested and equal amounts (100 mg) of cell
lysates immunoprecipitated with Cdk2 antibody (A). The resulting im-
munoprecipitates were assayed for kinase activity using either Rb or
histone H1 as a substrate as previously described (Bresnahan et al.,
1996; Dulic et al., 1992). Cell lysates were also immunoprecipitated
with either cyclin E or cyclin A antibodies and assayed for kinase
activity using histone H1 as a substrate (B).
precipitates were assayed for Cdk2 kinase activity. Fig-
ure 1A shows that HCMV infection results in a dramatic
increase in Cdk2 kinase activity using both histone H1
and Rb as substrates. Kinase assays were also done on
cyclin E and cyclin A immunoprecipitates from HCMV-
infected cells. HCMV infection results in an increase in
cyclin E kinase activity with no induction of cyclin A ki-
nase activity (Fig. 1B). These results demonstrate that
the Cdk2 activity that is induced in HCMV-infected cells
is due to cyclin E/Cdk2 complexes and not cyclin A/Cdk2
complexes (Bresnahan et al., 1996).
Roscovitine inhibits HCMV replication
We have used an inhibitor of Cdk2 activity, roscovitine
FIG. 2. Inhibition of cyclin E/Cdk2 activity, HCMV DNA synthesis and
(Meijer, 1996; Rudolph et al., 1996), to determine if Cdk2 virus yields by roscovitine. LU cells were growth arrested by contact
activity is necessary for HCMV replication. The IC50 for inhibition and infected with HCMV. 48 hr postinfection cell lysates were
prepared, 100 mg of total protein was immunoprecipitated with cyclincyclin E/Cdk2 inhibition in vitro by roscovitine is 0.7 mM
E antibody, and in vitro kinase activity was determined in the presence(Meijer, 1996; Rudolph et al., 1996). We determined if
of the indicated concentration of roscovitine (A). Cells were also in-roscovitine could inhibit cyclin E/Cdk2 activity from
fected and treated with various concentrations of roscovitine following
HCMV-infected cells at similar concentrations. Cell ly- infection. (B) 72 hr postinfection, the cells were harvested, total DNA
sates were prepared from LU cells that had been infected was isolated, and the abundance of HCMV DNA was determined by
slot blot hybridization using a specific HCMV DNA probe. (C) 96 hrwith HCMV for 48 hr and assayed for cyclin E/Cdk2 ki-
postinfection, infected cells were lysed by freeze–thaw, followed bynase activity in the presence of various concentrations
sonication. Cellular debris was removed by sedimentation and theof roscovitine. Figure 2A shows that roscovitine inhibited
HCMV containing supernatant fluids were assayed for infectivity by
cyclin E/Cdk2 kinase activity in a dose-dependent man- plaque assay as described previously (Albrecht and Weller, 1980). Val-
ner with cyclin E/Cdk2 activity being inhibited by greater ues represent the average of three independent experiments with stan-
dard errors shown.than 95% at 2.5 mM. We also determined if roscovitine
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2.5 mM roscovitine, and 99.9% inhibition occurred at
10 mM. Since the IC50 for roscovitine inhibition of Cdk2
in vitro is 0.7 mM (Meijer, 1996; Rudolph et al., 1996), the
observation that both viral DNA synthesis and production
of infectious virus particles is inhibited 50% at about 1
mM roscovitine suggests that inhibition of Cdk2 accounts
for inhibition of viral DNA replication. Similar results were
obtained when olomoucine, a Cdk2 inhibitor that is struc-
turally related to roscovitine (Meijer, 1996), was used
(data not shown); however, the concentration of olomou-
cine that was required to inhibit viral DNA synthesis and
virus yield was about 10-fold higher than the correspond-
ing concentration of roscovitine. The IC50 for olomoucine-
mediated inhibition of Cdk2 in vitro is 7 mM (Vesely et
al., 1994), 10-fold higher than that of roscovitine.
To test whether drug-associated cellular toxicity was
responsible for the reduced HCMV replication we investi-
gated the effects of both roscovitine and olomoucine on
noninfected cells. In these experiments, neither roscovi-
tine nor olomoucine demonstrated any detectable toxic
effects on noninfected cells. No changes in cell morphol-
ogy were observed over 96 hr in the presence of 15 mM
roscovitine (data not shown). In addition, more than 70%
of the cells that had been exposed to roscovitine or olo-
moucine in this fashion were able to incorporate bromo-
deoxyuridine (BrdU) within 24 hr after removal of the in-
hibitor (Fig. 3B). Similar results were obtained when rosc-
ovitine- or olomoucine-treated cells were analyzed for
cell cycle progression (using flow cytometry) after re- FIG. 3. Effects of roscovitine on noninfected LU cells. LU cells were
moval of the drug (Fig. 3A). treated with 15 mM roscovitine for 96 hr. After 96 hr, the cells were
HCMV, like other herpesviruses, undergoes a sequen- stained with propidium iodide and analyzed by flow cytometry (A). In
parallel, the roscovitine containing medium was removed and replacedtial order of gene expression whose phases have been
with fresh EMEM containing 10% FBS or EMEM containing 10% FBSdesignated immediate early, early, and late following in-
and bromodeoxyuridine. Cells were harvested 24 hr after removal offection of permissive cells (Wathen and Stinski, 1982). roscovitine and analyzed for cell cycle progression by flow cytometry
HCMV immediate early genes are expressed within 1 hr (A) and bromodeoxyuridine incorporation (B).
after infection (Boldogh et al., 1991), well before viral
activation of cyclin E/Cdk2 (Bresnahan et al., 1996), sug-
are consistent with the hypothesis that roscovitine, likegesting that immediate early expression is not dependent
PAA, blocks viral DNA replication at some point afteron Cdk2 activation. Indeed expression of the HCMV ma-
expression of immediate early genes, but prior to thejor immediate early proteins (IE72 and IE86) was not
initiation of the late phase of HCMV replication. Thisinhibited by roscovitine, in two cell lines (LU and U-373)
effect can be demonstrated in at least two cell lines thatwhich support productive HCMV infection (Bresnahan et
are known to be productive for HCMV infection.al., 1996; Ripalti et al., 1995; Dal Monte et al., 1996) as
shown in Fig. 4A. On the other hand, expression of
Expression of dominant negative mutant Cdk2 inhibits
UL80.5 late HCMV gene products (Welch et al., 1991)
HCMV replication
was inhibited by roscovitine (Fig. 4B). The results ob-
tained with phosphonoacetic acid (PAA) are shown for Both roscovitine and olomoucine inhibit Cdk1, as well
as Cdk2 (Meijer, 1996; Vesely et al., 1994). Both Cdk1comparison. PAA, a well-characterized inhibitor of HCMV
DNA polymerase, inhibits viral DNA synthesis (Huang, and Cdk2 are inhibited at similar concentrations of ros-
covitine, and inhibition of HCMV replication could be due1975). PAA inhibits expression of HCMV late genes (e.g.,
UL80.5; Fig. 4B) since expression of late genes is, by to inhibition of either enzyme. A previously characterized
dominant negative Cdk2 mutant (van den Heuvel anddefinition, dependent upon viral DNA synthesis (Wathen
and Stinski, 1982; Honess and Roizman, 1975). However, Harlow, 1993) was used to test directly the hypothesis
that the effects of roscovitine on HCMV replication arePAA has no effect on those HCMV genes that are ex-
pressed prior to initiation of viral DNA synthesis (Wathen due to inhibition of Cdk2. This hypothesis predicts that
expression of the dominant negative Cdk2, which resultsand Stinski, 1982). The results shown in Figs. 2A and 4
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(shown in Fig. 6B) did not express UL80.5 late antigens
(Fig. 6D). Cells that expressed wild-type Cdk2 (Fig. 6A)
supported viral replication, as evidenced by expression of
the UL80.5 late gene products (Fig. 6C). Three independent
experiments of this kind were done; and the percentage of
infected cells, cells expressing Cdk2-wt-HA plus UL80.5,
and cells expressing Cdk2-dn-HA plus UL80.5 were deter-
mined. Transfection efficiencies were similar for both wild-
type and dominant negative Cdk2 (data not shown). As
shown in Table 1, about 33% of the cells in the infected
cultures expressed UL80.5 late antigens. This efficiency of
infection was observed irrespective of whether the cells
were transfected with wild-type or dominant negative deriv-
atives of Cdk2. The susceptibility of U-373 cells to HCMV
in our experiments is consistent with published data (Ripalti
et al., 1995). The efficiency of transient expression of Cdk2
derivatives is much lower than the frequency of virus infec-
tion. We estimate that5% of the U-373 cells, and therefore
2% of the infected cells, express HA-tagged Cdk2 deriva-
tives. Similar results were obtained with b-galactosidase
expression vectors (data not shown). Nevertheless, about
37% of the cells that expressed the wild-type HA-tagged
Cdk2 derivative also expressed UL80.5 late antigens. The
FIG. 4. Expression of HCMV immediate early and late antigens fol- percentage of wild-type Cdk2-transfected cells that ex-
lowing treatment with roscovitine. LU or U-373 cells were infected with pressed viral late antigens was not significantly different
HCMV. Infected cells were either untreated or treated with roscovitine
from the percentage of HCMV-infected cells in the culture(15 mM) or phosphonoacetic acid (750 mM). (A) Infected cell lysates
(P  0.05). This observation demonstrates that transientwere prepared 8 hr postinfection. Equal amounts of protein (40 mg) were
separated by SDS – PAGE, transferred to nitrocellulose, and probed with expression of HA-tagged wild-type Cdk2 derivative has no
antibody against HCMV immediate early proteins. (B) Lysates were significant effect on viral replication, as assessed by ex-
prepared 72 hr postinfection and assayed by immunoblotting for HCMV pression of viral late antigen. On the other hand, only 2%
UL80.5 abundance as described above.
of cells that expressed the dominant negative Cdk2 mutant
also expressed UL80.5 late antigens (P  0.0001). This
observation indicates that Cdk2 activity is vital for HCMVin inhibition of Cdk2 activity (van den Heuvel and Harlow,
1993), should be sufficient for inhibition of HCMV replica- replication and inhibition of Cdk2 is sufficient to inhibit viral
replication.tion. U-373 cells were used in these experiments be-
cause of the low efficiency of transfection of LU cells. U-
373 cells were transiently transfected with expression DISCUSSION
vectors encoding hemagglutinin (HA)-tagged wild-type
A number of studies have revealed that productive
Cdk2 (pCMVCdk2-wt-HA) or HA-tagged dominant nega-
HCMV infection provokes arrested cells to enter the cell
tive Cdk2 (pCMVCdk2-dn-HA). The hemagglutinin tag
allows us to distinguish between endogenous and exog-
enous Cdk2 by the use of a specific hemagglutinin anti-
body. Cells were harvested 48 hr after transfection and
assayed for Cdk2-wt-HA and Cdk2-dn-HA expression
and kinase activity. Western blotting with HA antibody
showed that cells transfected with either wild-type or
dominant negative Cdk2 expressed the exogenous pro-
tein (Fig. 5). Histone H1 kinase activity was associated
with Cdk2 wild-type HA immunoprecipitates, but not with
the Cdk2 dominant negative HA precipitates (Fig. 5).
To determine if Cdk2 activity is required for HCMV repli-
cation, dual immunofluorescent staining was used to assay
FIG. 5. Expression and activity of wild-type and dominant negativefor expression of the HA-tagged Cdks and for the HCMV
cdk2. U-373 cells were transiently transfected with either HA-tagged
late antigens encoded by UL80.5, in transfected U-373 cells wild type Cdk2 (Cdk2-wt-HA) or dominant negative Cdk2 (Cdk2-dn-HA).
that were also infected with HCMV. As shown in Fig. 6, Cells were then harvested 48 hr later and assayed for HA expression
(Western) and HA-associated kinase activity (Histone H1).cells that expressed the dominant negative Cdk2 mutant
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FIG. 6. Inhibition of HCMV late antigens in cells expressing dominant negative Cdk2. U-373 cells were transiently transfected with either HA-
tagged wild-type Cdk2 (Cdk2 wild type) or dominant negative Cdk2 (Cdk2 dominant negative). Cells were then seeded onto glass coverslips and
infected with HCMV 24 hr after transfection. The cells were fixed 72 hr postinfection with acetone:methanol (1:1) and dual immunofluorescent
staining was done for HCMV UL80.5 (rhodamine) and HA (FITC) expression. (A and B) HA antigen (Cdk2) was detected by fluorescein fluorescence
to demonstrate cells expressing either wild-type or dominant negative Cdk2. (C and D) HCMV UL80.5 late antigens were detected by rhodamine
fluorescence. The identical field of cells is shown in A and C. An identical field of cells is also illustrated in B and D.
cycle (reviewed in Albrecht et al., 1989). Recent studies synthesis. Among those genes whose expression is reg-
ulated by E2F are c-myc, c-myb, dihydrofolate reductase,have confirmed these early observations and demon-
strated that productively infected cells traverse the cell thymidine kinase, and DNA polymerase a (see Weinberg,
1995; Farnham et al., 1993 and references therein). In-cycle through at least late G1 (Bresnahan et al., 1996; Lu
and Shenk, 1996; Jault et al., 1995; Poma et al., 1996; creased expression of these genes is required for post-
mitotic cells to enter S phase and support DNA synthesis.Dittmer and Mocarski, 1997) and induce cyclin E/Cdk2
activity (Bresnahan et al., 1996; Jault et al., 1995). Pre- Productive HCMV infection also results in increased ex-
pression of c-myc (Boldogh et al., 1990; Monick et al.,viously, we have shown that HCMV infection causes the
translocation of Cdk2 into the nucleus,3 reduces the 1992), dihydrofolate reductase (Wade et al., 1992), and
thymidine kinase (Estes and Huang, 1977). In the caseabundance of two Cdk2 inhibitors (Cip1 and Kip1), and
induces a robust increase in cyclin E abundance and its of dihydrofolate reductase, activation by HCMV requires
E2F in combination with an immediate early viral geneassociated kinase activity (Bresnahan et al., 1996). In
cells stimulated to traverse the cell cycle by serum product IE-72 (Margolis et al., 1995). Phosphorylation of
pRB has also recently been observed in HCMV-infectedgrowth factors, cyclin E/Cdk2 acts in part by phosphory-
lating pRB, which results in the release of the transcrip- cells (Jault et al., 1995; our unpublished studies). Collec-
tively, these findings suggest an important role for Cdk2tion factor E2F (Nevins, 1992; Weinberg, 1995). E2F can
then transcriptionally activate a number of E2F respon- in HCMV replication.
The present findings clearly demonstrate the require-sive genes that are required for efficient cellular DNA
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TABLE 1
Percentage of Cells Expressing Cdk2-HA and HCMV UL80.5 Antigens
Mean %
Cells expressing Experiment 1 Experiment 2 Experiment 3 (/SD)
UL80.5 antigens 52/156 46/156 53/150 33 ({ 2)
33% 30% 35%
pCMVCdk2-wt-HA
58/148 56/154 53/147 37 ({1)/
39% 37% 36% P  0.05
UL80.5 antigens
pCMVCdk2-dn-HA
3/151 5/161 4/159 2.6 ({0.6)/
2% 3% 3% P  0.0001
UL80.5 antigens
Note. U-373 cells were transiently transfected with HA-tagged wild-type or dominant negative Cdk2 and subsequently infected with HCMV. The
percentage of infected cells was determined by measuring expression of HCMV UL80.5 antigens. Multiple random fields were counted to accumulate
about 150 total cells, about one-third of which expressed UL80.5. The percentage of cells expressing UL80.5 antigens was also determined from
cells expressing HA-tagged wild-type or dominant negative Cdk2. In this case, multiple fields were counted to accumulate about 150 HA-positive
cells, which were scored for expression of UL80.5. Statistical significance was estimated by Student’s t test, comparing infected cells expressing
HA to the percentage of infected cells in the cultures.
ment for Cdk2 activity in the replication of HCMV. Inhibi- for relieving the impediments to cell cycle progression
in postmitotic cells. Furthermore, since IE72 expressiontion of Cdk2 activity by drugs or a dominant negative
inhibitor blocks HCMV replication. However, these stud- is not blocked by the inhibitors of Cdk2 activity used in
this study, our data suggest that the presence of IE72 inies do not elucidate the precise mechanism by which
Cdk2 participates in HCMV replication. We have hypothe- the absence of Cdk2 activity may not be sufficient for
efficient HCMV replication in postmitotic cells.sized that Cdk2 activity may be required to phosphorylate
the retinoblastoma tumor suppressor protein allowing for Although several studies have suggested that substan-
tial cellular DNA synthesis occurs in cells productivelyrelease of E2F and transcription of cellular and/or viral
genes required for HCMV replication (Bresnahan et al., infected by HCMV (Jault et al., 1995; Poma et al., 1996;
Morin et al., 1996), most recent studies in which the1996). To investigate this hypothesis further it will be
necessary to determine if Cdk2 is responsible for the confounding effects of serum have been avoided and
the contributions of cellular and viral DNA have beenphosphorylation of pRb that one observes during HCMV
infection and that upon phosphorylation of Rb there is a evaluated carefully have observed that cellular DNA syn-
thesis is inhibited in cells productively infected by HCMVsubsequent release of E2F. However, Cdk2 activity may
also play another role in HCMV replication. Cdk2 activity (Bresnahan et al., 1996; Lu and Shenk, 1996; Dittmer
and Mocarski, 1997). The absence of an increase in thehas been reported to be involved in the initiation of cellu-
lar DNA synthesis at origins of replication (Jackson et abundance or activity of cyclin A in cells productively
infected by HCMV (Bresnahan et al., 1996) would seemal., 1995). It is entirely possible that Cdk2 activity may
also play a similar role in initiating HCMV DNA synthesis. to preclude the possibility of substantial levels of cellular
DNA synthesis in these infected cells. These findingsThe fact that inhibition of Cdk2 activity by chemical inhibi-
tors blocks HCMV replication sometime after IE gene suggest that HCMV has a distinctly different mechanism
for circumventing the constraints placed upon viral repli-expression, but prior to initiation of viral DNA synthesis,
is consistent with either hypothesis. cation in postmitotic cells from those recognized for
small DNA viruses such as papovaviruses. Even thoughIf cyclin E/Cdk2 activity is involved in phosphorylating
Rb and releasing E2F, it may not be the only mechanism HCMV replication does not require cellular DNA synthe-
sis, the present findings, as well as earlier studies, indi-whereby the virus accomplishes release of E2F in HCMV-
infected cells. Poma et al. (1996) have reported that one cate that HCMV replication does depend on those cellu-
lar events that prepare postmitotic cells for DNA synthe-of the HCMV IE proteins (IE72) interacts with the RB-
related protein p107 and relieves the transcriptional re- sis (reviewed in Albrecht et al., 1989).
The sensitivity of HCMV replication to the Cdk2 inhibi-pression of an E2F-responsive promoter mediated by
p107. Both p107 and pRB are proposed to undertake tors roscovitine and olomoucine is noteworthy. It has not
escaped our attention that the use of the Cdk2 inhibitorsimportant roles in the regulation of cell cycle progression
(Cao et al., 1992; Weinberg, 1995). The data provided by roscovitine or olomoucine may provide novel drugs to
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